Key takeaways
Androxy (fluoxymesterone) and Methitest (methyltestosterone) are both medications used to treat low testosterone in males and breast cancer in females. However, there are some key differences between the two. Androxy (fluoxymesterone) is no longer available in the United States, while Methitest (methyltestosterone) is still available by prescription. Methitest (methyltestosterone) is a man-made form of testosterone that is more easily absorbed by the body compared to natural testosterone. It is also known for its serious liver side effects, which makes it less commonly used. Androxy (fluoxymesterone) was discontinued because of safety profile, but there are other forms of testosterone replacement therapies available. Both medications are controlled substances due to their potential for abuse and dependency. Methitest (methyltestosterone) has additional risks, such as causing high calcium levels in females with breast cancer and fast bone maturation in children.
